BiPar Sciences Co-founder Reunites Management Team At TriAct Therapeutics to Advance Clinical Stage Cancer Programs SAN FRANCISCO, Sept. 10, 2009 (GLOBE NEWSWIRE) -- Tom White, cofounder and former chief executive officer (CEO) of BiPar Sciences, the successful biotech firm recently acquired by Sanofi-Aventis for...